Condensed Balance Sheets - USD ($)		Mar. 31, 2025	Dec. 31, 2024
Current assets
Deferred offering costs		$ 1,140,160	$ 622,778
Total Assets		1,140,160	622,778
Current Liabilities
Accrued expenses		16,020	25,920
Accrued offering costs		572,716	575,875
Promissory note - related party		158,864	60,400
Total Current Liabilities		747,600	662,195
Deferred legal fees		450,078	0
Total Liabilities		1,197,678	662,195
Commitments and Contingencies (Note 5)
Shareholders' Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding		0	0
Additional paid-in capital		169,329	24,329
Accumulated deficit		(227,518)	(64,417)
Total Shareholders' Deficit		(57,518)	(39,417)
Total Liabilities and Shareholders' Deficit		1,140,160	622,778
Class A ordinary share [Member]
Shareholders' Deficit
Ordinary shares		0	0
Class B ordinary share [Member]
Shareholders' Deficit
Ordinary shares	[1]	$ 671	$ 671

[1] Includes up to 875,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 4). Subsequently on May 16, 2025, the Company consummated the Initial Public Offering of 20,125,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the amount of 2,625,000 Units and as such 875,000 Class B ordinary shares are no longer subject to forfeiture.